It is a secret, oncologists rarely share with their patients: Around 25 percent of all cancers are currently considered untreatable, and the prognosis is worse for colon (colorectal) and lung cancers, with half of these immune to chemotherapy.

This is a story about coffee—to be precise: about eating coffee. It is also a story about potentially the largest—and surely the only profitable—regeneration of nature project ever undertaken. It is a story that begins in a small country with two million inhabitants on the Baltic Sea between Lithuania and Estonia.

Edward was a successful businessman with companies on both the East and West coasts of the United States. He would meet with his accountants and add columns of numbers immediately in his head before the accountants could do so on their calculators. As he approached 60, however, he began to have memory problems. One day at the gym, he panicked when he forgot the combination to his locker, and his lock had to be cut.

The print edition of KAMP SOLUTIONS magazine presents a major innovation. It provides a solution to some of the biggest environmental challenges people and planet face. The story of the production of this magazine will change the way you think about paper and it will introduce you to inspiring opportunities to regenerate nature and reverse global warming as well as to groundbreaking business opportunities that will revolutionize the packaging industry.

Economist Stephanie Kelton argues for a radical shift in economic thinking to better deal with crucial challenges societies face—from poverty and inequality to creating jobs and reversing global warming.

There are two stories about the origins of modern money. One is the story as most of us know it: Money started as shells to facilitate barter between, say, fishermen and farmers.

The Covid-19 pandemic has taught us a couple of things: We cannot take what we hear or read at face value, and it is up to all of us to join the dots for ourselves.

We already know that the SARS-CoV-2 virus, which causes Covid, is twice as virulent as seasonal flu, from the same SARS family, which puts its mortality rate at around 0.4 percent. For more than 90 percent who get the virus, it will cause mild symptoms. According to health agencies, 30 percent will not even know they have it, and will be entirely symptom-free, or asymptomatic.